Assessment of vocal quality following treatment of advanced pharyngo-laryngeal carcinoma with a protocol of organ preservation

被引:2
|
作者
Morato-Galan, Marta [1 ]
Caminero Cueva, Maria Jesus [2 ]
Pablo Rodrigo, Juan [1 ,3 ]
Suarez Nieto, Carlos [1 ,3 ]
Nunez-Batalla, Faustino [1 ]
机构
[1] Hosp Univ Cent Asturias, Serv Otorrinolaringol, Oviedo, Asturias, Spain
[2] Hosp Univ Cent Asturias, Serv Oncol Radioterap, Oviedo, Asturias, Spain
[3] Univ Oviedo, Inst Univ Oncol Principado Asturias, Oviedo, Asturias, Spain
来源
ACTA OTORRINOLARINGOLOGICA ESPANOLA | 2014年 / 65卷 / 05期
关键词
Head and neck cancer; Voice analysis; Functional outcomes;
D O I
10.1016/j.otorri.2013.12.005
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction and objectives: Advanced laryngeal and pharyngeal cancer, as well as methods to treat them, have a direct impact on voice function, speech communication and deglutition. Such alterations in function can influence employability and general quality of life. Patients and methods: To characterise the vocal status of the patients treated with an organ preservation protocol, we report the voice outcomes of 17 patients who were alive and disease free at the time of the survey, with a minimum follow-up of 6 months, after a combination of radiotherapy and chemotherapy to treat advanced cancer. Objective voice assessment by means of spectrographic analysis, the GRBAS perceptual analysis system and the Voice Handicap Index was the methodology followed, which we suggest could be used in future large-scale investigations. Results: Normal or slightly dysphonic voices were observed in 5 patients (29.4%) and moderate/severe in 12 (70.6%). Spectrographically, the 17 samples were classified as normal in 4 cases (23.4%), Grade I in 3 cases (17.6%), Grade II in 3 (17.6%), Grade III in 4 (23.5%) and Grade IV in 2 (11.7%). The Voice Handicap Index questionnaire, which was completed by the patients themselves, gave normal results in all the patients except for 4 (23.5%). Conclusions: The voice acoustic analysis of this series shows that the damage related to the organ-preservation protocol displays a relatively wide range of voice function outcomes. To characterise the vocal status of these patients reliably, we propose using homogeneous instruments (spectrography, GRBAS scale, Maximum Phonation Time and Voice Handicap Index) in future meta-analyses. (C) 2013 Elsevier Espana, S.L.U. y Sociedad Espanola de Otorrinotaringologia y Patologia CervicoFacial. All rights reserved.
引用
收藏
页码:283 / 288
页数:6
相关论文
共 50 条
  • [21] Survival and organ preservation following surgical treatment for hypopharynx carcinoma
    Eckel, HE
    Jungehuelsing, M
    Schroeder, U
    Volling, P
    Betten, T
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S169 - S169
  • [22] Organ preservation in advanced laryngeal/hypopharyngeal carcinoma: lessons from the DeLOS-II trial
    Dietz, A.
    Wichmann, G.
    Kuhnt, T.
    Wiegand, S.
    HNO, 2020, 68 (09) : 648 - 656
  • [23] Functional Organ Preservation in Locally Advanced Laryngeal Squamous Cell Carcinoma: Is there a Role for Induction Chemotherapy?
    Loo, S. W.
    Geropantas, K.
    Rogues, T. W.
    CLINICAL ONCOLOGY, 2013, 25 (05) : 298 - 307
  • [24] THE RESULTS AND TOXICITY OF ORGAN PRESERVATION TREATMENT IN PATENTS WITH LOCOREGIONALLY ADVANCED LARYNGEAL AND HYPOPHARYNGEAL CANCER.
    Kiprian, D.
    Kawecki, A.
    Jarzabski, A.
    Pawlowska-Sendulka, B.
    Michalski, W.
    RADIOTHERAPY AND ONCOLOGY, 2011, 98 : S34 - S34
  • [25] Results of total laryngectomy as treatment for locally advanced laryngeal cancer in the organ-preservation era
    Rodrigo, Juan P.
    Lopez, Fernando
    Llorente, Jose L.
    Alvarez-Marcos, Cesar
    Suarez, Carlos
    ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2015, 66 (03): : 132 - 138
  • [26] Suboptimal regimens in sequential treatment (ST) with ICT (induction chemotherapy) followed by CCRT (concomitant chemotherapy) in "real life" patients with locally advanced pharyngo-laryngeal squamous-cell carcinoma (LAPLSCC) and prognosis
    Orte, Carmen
    Pajares Bernad, Isabel
    Ortega Izquierdo, Eugenia
    Vicente Gonzalez, Eugenio
    Bonaga Serrano, Beatriz
    Terre Falcon, Ramon
    Roque Taveras, Lucrecia
    Martinez-Trufero, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer
    Guadagnolo, BA
    Haddad, RI
    Posner, MR
    Weeks, L
    Wirth, LJ
    Norris, CM
    Sullivan, CA
    Goguen, L
    Busse, PM
    Tishler, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (04): : 371 - 378
  • [28] Organ preservation by weekly paclitaxel and carboplatin concurrent with radiation therapy in locally advanced laryngeal/hypopharyngeal carcinoma.
    Memon, M
    Al Amro, A
    Al-Rajhi, N
    Rahal, M
    El-Sebaie, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 515S - 515S
  • [29] Functional outcomes following nonsurgical treatment for advanced-stage laryngeal carcinoma
    Meleca, RJ
    Dworkin, JP
    Kewson, DT
    Stachler, RJ
    Hill, SL
    LARYNGOSCOPE, 2003, 113 (04): : 720 - 728
  • [30] Efficacy of non-surgical larynx-preservation comprehensive treatment in advanced laryngeal carcinoma
    Chen NanXiang
    Fan WenJun
    Ma Lin
    Wang JiaLing
    Wu WenMing
    Zhang XinXin
    中华医学杂志英文版, 2020, 133 (05) : 615 - 616-617